Mothers of schizophrenic patients: medical and psychological aspects of the problem

Thus, we can talk about the obvious mutual influence between a child with schizophrenia and his mother. On the one hand, it can be manifested in the form of the fact that a certain number of personal characteristics of the mother is accompanied by the formation of high rates of schizoid and neurotic child. Of course, the presence of a certain psychological type of mother (as the only reason) is not enough for the emergence and development of schizophrenia, but the subsequent development of the child’s personal disorders, as a borderline between the norm and pathology, can already be the ground for the development of the disease in the presence of other more significant causes (for example, hereditary). On the other hand, the disease of the child can be a significant stress factor for the mother, leading to the formation of her manifestations of emotional stress and psychological maladjustment, which, in turn, can adversely affect not only the features of her relationship with the child, but also on the features of the course of his disease. The mechanisms of formation of such a «vicious circle» are poorly studied even theoretically, not to mention the fact that in routine psychiatric practice these issues do not fall into the focus of the psychiatrist’s attention, are not taken into account in the development of therapy strategy. However, the parameters of interaction between mother and child, the level of their mutual empathy, can be important for the formation of compliance in the treatment of schizophrenia, as the «conductor» of therapy in relation to a small patient is the mother. There is also no doubt that the level of mental health of the mother is an important resource for maintaining the viability of the whole family system and, in particular, a necessary condition for the organization of adequate therapy for a child with schizophrenia. Therefore, the study of the issues of mutual influence of the patient with schizophrenia and his mother, the development of ways to correct the problems arising in this case are an important scientific and practical task of modern psychiatry.

1. Smulevich AB. Low progreduated schizophrenia and borderline conditions. Moscow: MED press Inform; 2009. (in Russ.)

2. Dyachenko LI. Organization of psychiatric care for patients with schizophrenia. In: Schizophrenia: New Approaches to Therapy: Collection of Scientific Works of the Ukrainian Research Institute of Clinical and Experimental Neurology and Psychiatry and Kharkiv City Clinical Psychiatric Hospital No. 15 (Saburova Dachi); 1995. (in Russ.)

3. Tandon R, Keshavan MS, Nasrallah HA. Schizophrenia: Just the Facts What we know. Schizophr Res. 2008;102(1-3):1-18. doi: 10.1016/j.schres.2008.04.011.

4. Mental Health: Enhancing the Fight against Mental Disorders. The World Health Organization newsletter. 2010;220:12. (in Russ.)

5. Jones P, Cannon M. The new epidemiology of schizophrenia. Psychiatr. Clin. Nort. Am. 1998;21(1):1-25.

6. Roffman JL, Brohawn DG, Nitenson AZ, Macklin EA, Smoller JW, Goff DC. Genetic Variation Throughout the Folate Metabolic Pathway Influences Negative Symptom Severity in Schizophrenia. Schizophr. Bull. 2013;39(2):330-8. doi: 10.1093/schbul/sbr150

7. Susser E, Neugebauer R, Hoek HW, Brown AS, Lin S, et al. Schizophrenia after prenatal famine. Further evidence. Arch. Gen. Psychiatry. 1996;53(1):25-31. DOI: 10.1001/archpsyc.

8. 01830010027005

9. Abritalin EYu, Aleksandrovsky YuA, Ananyeva NI, et al. Psychiatry: national management (2nd edition, revised and augmented). Moscow; 2018. (in Russ.)

10. Górna K, Jaracz K, Jaracz J, Kiejda J, Grabowska-Fudala B, Rybakowski J. Social functioning and quality of life in schizophrenia patients: relationship with symptomatic remission and duration of illness. Psychiatia Polska. 2014;48(2):277–288. (in Polish)

11. Abramov VА, Putsay SА, Kutko II. Functional diagnostics of mental diseases (methodical recommendations). - Donetsk: Donetsk State Medical Institute; 1990. (in Russ.)

12. Semenov SF. Some features of the clinic and the course of schizophrenia with autoimmunization phenomena with brain antigens. Journal of Neuropathology and Psychiatry. 1964;64(3):398.

13. Semenov SF. Schizophrenia. Kiev: Medical publishing house of the USSR; 1961. (in Russ.)

14. Smulevich AB. Low progreduated schizophrenia and borderline conditions. Moscow: MED press Inform; 2009. (in Russ.)

15. Fuller Torrey E. Schizophrenia. A book to help doctors, patients and their families. SPb: Peter Press; 1996. (in Russ.)

16. Karlsson A. Progress of the dopamine theory of schizophrenia: Reference publication for doctors. 2003. (in Russ.)

17. Aleksandrovsky Yu.A. Predsheezey conditions and borderline mental disorders (etiology, pathogenesis, specific and nonspecific symptoms, therapy). Moscow: Litterra; 2010. (in Russ.)

18. Bukhanovsky AO, Vilkov GA, Dubatova IV, Perekhov AYa, Cherenkov SA. Use of plasmapheresis in schizoaffective psychoses. “Affective and schizoaffective psychoses”. Conference proceedings. Moscow; 1998:408–409. (in Russ.)

19. Kotelnikov GP, Shpigel AS, Kuznetsov SI, Lazarev VV. Introduction to evidence-based medicine. Scientifically based medical practice: a manual for doctors. Samara: Samara State Medical University; 2001. (in Russ.)

20. Dubatova IV, Vilkov GA. Experience of using the basic parameters of the functions of certain homeostasis systems for diagnosing, predicting and treating endogenous psychoses. Scientific and Practical Conference of Psychiatrists in Southern Russia “Psychiatry at the Turn of the Millennium”. Conference proceedings. Rostov-on-Don; 1999:164–166. (in Russ.)

21. Dubatova IV. The influence of “shock” therapies on the processes of free radical oxidation and antioxidant protection in patients with schizophrenia. First Scientific Session of the Russian State Medical University. Session materials. Rostov-on-Don; 1996: 39. (in Russ.)

22. Soldatkin VA, eds. Short Course in Psychiatry. Rostov-on- Don; 2019 (in Russ.)

23. Zhislin SG. Sketches of Clinical Psychiatry. Moscow: Medicine; 1965. (in Russ.)

24. Zatsepitsky RA. Psychological aspects of psychotherapy of patients with neurosis. In: Actual issues of medical psychology. L.: Medicine; 1974: 54–69. (in Russ.)

25. Isurina G. L., Karvasarsky B. D., Leder S., Tashlykov V. A., Tupitsyn Yu. Ya. Development of pathogenetic concept of neuroses and psychotherapy V. N. Myasishchev at the present stage. In: Theory and practice of medical psychology and psychotherapy. SPb.; 1994:100-109. (in Russ.)

26. Rössler W, Salize HJ, van Os J, Riecher-Rössler A. Size of burden of schizophrenia and psychotic disorders. Eur Neuropsychopharmacol 2005;15(4):399-409. DOI: 10.1016/j.euroneuro.2005.04.009

27. Kapur S. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry. 2003;160(1):13-23. DOI: 10.1176/appi.ajp.160.1.13

28. Harrison PJ, Weinberger DR. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Molec. Psychiatry. 2005;10(1):40-68. DOI: 10.1038/sj.mp.4001558

29. Owen MJ, Williams NM, O’Donovan MC. The molecular genetics of schizophrenia: new findings promise new insights. Molec. Psychiatry. 2004;9(1):1427. DOI: 10.1038/sj.mp.4001444

30. Torrey EF, Taylor EH, Bracha HS, Bowler AE, McNeil TF, et al. Prenatal origin of schizophrenia in a subgroup of discordant monozygotic twins. Schizophr. Bull. 1994;20(3):42332. DOI: 10.1093/schbul/20.3.423

31. Bukhanovsky A.O. Some features of the clinic of family schizophrenia // Abstract of the abstract - 1977. 20-25.

32. Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophreniaassociated genetic loci. Nature. 2014;511(7510):421-7. doi: 10.1038/nature13595.

33. Laruelle M. The role of endogenous sensitization in the pathophysiology of schizophrenia: Implications from recent brain imaging studies. Brain Research Reviews. 2000;31(1-2):371-384.

34. Lisman JE, Coyle JT, Green RW, Javitt DC, Benes FM, et al. Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends in Neuroscience. 2008;31(5):234-242. doi: 10.1016/j.tins.2008.02.005

35. Lichko AE, Bitensky VS. Teenage Addiction Medicine. SPb.; 1991. (in Russ.)

36. Sekine Y, Iyo M, Ouchi Y, Matsunaga T, Tsukada H, et al. Methamphetamine-Related Psychiatric Symptoms and Reduced Brain Dopamine Transporters Studied With PET. American Journal of Psychiatry. 2001;158(8):1206—1214. DOI: 10.1176/appi.ajp.158.8.1206

37. Volkow ND. Drug Abuse and Mental Illness: Progress in Understanding Comorbidity. Am J Psychiatry. 2001;158(8):1181-3. DOI: 10.1176/appi.ajp.158.8.1181

38. Fabrega H. The self and schizophrenia: a cultural perspective. Jr Schizophr Bull. 1989;15(2):277-90. DOI: 10.1093/schbul/15.2.277

39. Chou IJ, Kuo CF, Huang YS, Grainge MJ, Valdes AM, et al. Familial Aggregation and Heritability of Schizophrenia and Co-aggregation of Psychiatric Illnesses in Affected Families. Schizophr Bull. 2017;43(5):1070-1078. doi: 10.1093/schbul/sbw159

40. Self-consciousness: an integrative approach from philosophy, psychopathology and the neurosciences. Kircher T., David AS eds. Cambridge University Press; 2003.

41. Nelson CW. Remembering Austin L. Hughes. Infect Genet Evol. 2016;40:262-265. doi: 10.1016/j.meegid.2016.02.030

42. Martin B, Wittmann M, Franck N, Cermolacce M, Berna F, Giersch A. Temporal structure of consciousness and minimal self in schizophrenia. Front Psychol. 2014;5:1175. doi: 10.3389/fpsyg.2014.01175.

43. Houston JE, Murphy J, Shevlin M, Adamson G. Cannabis use and psychosis: Re-visiting the role of childhood trauma. Psychol. Med. 2011;41(11):2339–2348. doi: 10.1017/

44. S0033291711000559

45. Konings M, Stefanis N, Kuepper R, de Graaf R, ten Have M, et al. Replication in two independent population-based samples that childhood maltreatment and cannabis use synergistically impact on psychosis risk. Psychol. Med. 2012;42(1):149–159. doi: 10.1017/S0033291711000973

46. Manrique-Garcia E, Zammit S, Dalman C, Hemmingsson T, Andreasson S, Allebeck P. Cannabis, schizophrenia and other non-affective psychoses: 35 years of follow-up of a population-based cohort. Psychol Med. 2012;42(6):1321–8. doi: 10.1017/S0033291711002078.

47. Parakh P, Basu D. Cannabis and psychosis: Have we found the missing links? Asian. J. Psychiatr. 2013;6(4):281–287. doi: 10.1016/j.ajp.2013.03.012

48. Varese F, Smeets F, Drukker M, Lieverse R, Lataster T, et al. Childhood adversities increase the risk of psychosis: a metaanalysis of patientcontrol, prospective- and cross-sectional cohort studies. Schizophr Bull. 2012;38(4):661–671. doi: 10.1093/schbul/sbs050.

49. Dobrokhotova TA. Neuropsychiatry. Moscow: BINOM; 2006. (in Russ.)

50. Lowry S, Mackintosh A. Schizophrenia (Part 2). Moscow: Media Sphere; 2003. (in Russ.)

51. Csernansky JG, Schindler MK, Splinter NR, Wang L, Gado M, et al. Abnormalities of thalamic volume and shape in schizophrenia. Am. J. Psychiatry. 2004;161:896-902. DOI: 10.1176/appi.ajp.161.5.896

52. Torrey EF, Rawlings RR, Ennis JM, Merrill DD, Flores DS. Birth seasonality in bipolar disorder, schizophrenia, schizoaffective disorder and stillbirths. Schizophr Res. 1996;21(3):141–149.

53. Barker DA, Shergill SS, Higginson I, Orrell MW. Patients’ views towards care received from psychiatrist. Brit J Psychiatry. 1996;168(5):641-646. DOI: 10.1192/bjp.168.5.641

54. Mortensen PB, Pedersen CB, Westergaard T, Wohlfahrt J, Ewalde H, et al. Effects of family history and place and season of birth on the risk of schizophrenia. NEJM. 1999;340:603–608. DOI: 10.1056/NEJM199902253400803

55. Vil’yanov VB, Egorov SV. Seasonal factors in the birth of patients with schizophrenia. Successes of modern natural science. 2002;2:31-36. (in Russ.)

56. Cheng C, Loh el-W, Lin CH, Chan CH, Lan TH. Birth seasonality in schizophrenia: effects of gender and income status. Psychiatry Clin Neurosci. 2013;67(6):426-456. doi: 10.1111/pcn.12076.

57. Ruggeri M, Lasalvia A, Dall’Agnola R, van Wijngaarden B, Knudsen HC, et al. Development, internal consistency and reliability of the Verona service satisfaction scale – European Version. EPSILON Study 7. European Psychiatric Services: Input Linced Outcome Domains and Needs. Br J Psychiatry Suppl. 2000;(39):s41-8.

58. Malm U, Lewander T; OTP Research group at the University of Gotlenburg; UKU; Scandinavian Society for Psychopharmacology. Consumer satisfaction in schizophrenia. A 2 year randomized controlled study of two communitybased treatment programs. Nord J Psychiatry. 2001;55(Suppl. 44):91-96. DOI: 10.1080/080394801317084446

59. Marriage K, Petrie J, Worling D. Consumer satisfaction with an adolescent inpatient psychiatric unit. Can J Psychiatry. 2001;46(10)969-975. DOI: 10.1177/070674370104601011

60. Comer R. Pathopsychology of behavior: violations and mental pathology: Per. from English. SPb.: Prime-EUROZNAK; M.: OLMA-press; 2005. (in Russ.)

61. Vilain J, Galliot AM, Durand-Roger J, Leboyer M, Llorca PM, et al. Environmental risk factors for schizophrenia: A review. Encephale. 2013;39(1):19-28. doi: 10.1016/j.

62. encep.2011.12.007.

63. Brown AS. Exposure to prenatal infection and risk of schizophrenia. Front Psychiatry. 2011;2:63-67. doi: 10.3389/

64. fpsyt.2011.00063

65. McGrath J, Welham J, Scott J, Varghese D, Degenhardt L, et al. Association between cannabis use and psychosis-related outcomes using sibling pair analysis in a cohort of young adults. Arch Gen Psychiatry. 2010;67(5):440-7. doi: 10.1001/

66. archgenpsychiatry.2010.6.

67. Cullen AE, Fisher HL, Roberts RE, Pariante CM, Laurens KR. Daily stressors and negative life events in children at elevated risk of developing schizophrenia. Br J Psychiatry. 2014;204:354-360. doi: 10.1192/bjp.bp.113.127001

68. Green JG, McLaughlin KA, Berglund PA, Gruber MJ, Sampson NA, et al. Childhood adversities and adult psychiatric disorders in the national comorbidity survey replication I: associations with first onset of DSM-IV disorders. Arch Gen Psychiatry. 2010;67(2):113-23. doi: 10.1001/archgenpsychiatry.2009.186.

69. Bochelyuk VI, Turubarov AV. Psychology of people with disabilities. Training aid. Moscow “Center for textbooks.”; 2011. (in Russ.)

70. Kalinina NV, Khayrudinova GI. Psychological features of parents raising children with disabilities, integrated into an inclusive educational environment. European Journal of Social Sciences. 2013;2(12):156-160. (in Russ.)

71. Moskovkina AG. Research Article. Socio-economic model of the family of a child with disabilities. Journal of Pedagogical Technologies Science and School. 2017;3;147 -151. (in Russ.)

72. Mishina GA. Ways of forming cooperation between parents and young children with developmental disabilities : Dis. ... kand. PED. Sciences. Moscow, 1998. (in Russ.)

73. Simak OYa, Soldatkin VA. Family of a schizophrenic patient as a promising focus of attention. Science Week - 2016. Materials of the All-Russian Youth Forum with international participation. 2016:506-509. (in Russ.)

74. Kanner L. Follow-up study of eleven autistic children originally reported in 1943. J Autism Child Schizophr. 1971;1(2):119-

75.

76. Politica OI. Social-psychological problems in children with disabilities. Herald of UGUES. 2015;3(13):64-72. (in Russ.)